# Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)

> **NCT02964741** · NA · TERMINATED · sponsor: **University of Michigan** · enrollment: 44 (actual)

## Conditions studied

- Migraine

## Interventions

- **DEVICE:** Active Comparator
- **DEVICE:** Sham Comparator

## Key facts

- **NCT ID:** NCT02964741
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-22
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-08-01
- **Target enrollment:** 44 (ACTUAL)
- **Why stopped:** due to COVID-19
- **Last updated:** 2022-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02964741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02964741, "Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02964741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*